Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Deferred Taxes (2024 - 2025)

Historic Deferred Taxes for Indivior Pharmaceuticals (INDV) over the last 2 years, with Q3 2025 value amounting to -$15.0 million.

  • Indivior Pharmaceuticals' Deferred Taxes fell 15000.0% to -$15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.0 million, marking a year-over-year change of. This contributed to the annual value of $7.0 million for FY2024, which is 11093.75% up from last year.
  • Latest data reveals that Indivior Pharmaceuticals reported Deferred Taxes of -$15.0 million as of Q3 2025, which was down 15000.0% from $9.0 million recorded in Q2 2025.
  • Over the past 5 years, Indivior Pharmaceuticals' Deferred Taxes peaked at $37.0 million during Q4 2024, and registered a low of -$27.0 million during Q2 2024.